Cancer Survivor, 750+ Advocates Push Congress on Research

When Lydia Epping was just seven years old, she faced kidney cancer. Last week, she returned to Washington with more than 750 cancer patients, survivors, and their families to make sure other kids won't have to fight the same battle alone.

The Crestview Hills resident joined the American Cancer Society Cancer Action Network's annual Leadership Summit and Lobby Day. She met directly with Kentucky's congressional delegation to push for increased funding for cancer research and prevention programs.

The numbers tell a powerful story. Over the past 30 years, steady federal investment in cancer research has fueled a 34% decline in cancer death rates nationwide. That progress didn't happen by accident—it came from consistent funding to agencies like the National Institutes of Health, the National Cancer Institute, and the Centers for Disease Control and Prevention.

Epping and her fellow advocates reminded lawmakers that this momentum depends on maintaining robust funding. Every dollar invested in research translates to new treatments, earlier detection methods, and ultimately, saved lives.

The group also championed the bipartisan Clinical Trial Modernization Act. This legislation would remove barriers that currently prevent many Americans from participating in clinical trials, particularly those in rural areas, older adults, certain racial and ethnic groups, and people with limited incomes.

Clinical trials represent hope for patients facing tough diagnoses. But access remains frustratingly uneven across the country. The proposed act would level the playing field, ensuring breakthrough treatments reach everyone who needs them.

The Ripple Effect

Epping's journey from seven-year-old patient to Capitol Hill advocate demonstrates how survivors become powerful voices for change. When 750 people share their stories with lawmakers, they put human faces to statistics and policy proposals.

The advocacy extends beyond individual meetings. Each conversation plants seeds for future legislation, budget decisions, and research priorities that will affect millions of Americans touched by cancer.

Federal research funding doesn't just benefit cancer patients. The scientific breakthroughs it enables often lead to treatments for other diseases, creating waves of progress across medicine.

When survivors like Epping speak up, they remind decision-makers that research dollars represent real people—children celebrating birthdays they might not have seen, parents watching their kids graduate, grandparents meeting newborns.

Their collective voice ensures that the incredible progress of the past three decades continues building toward a future where cancer loses its power to devastate families.